Attention-deficit/hyperactivity disorder (ADHD) symptoms in pediatric narcolepsy: A cross-sectional study

Sleep

Volumn 38, Issue 8, 2015, Pages 1285-1295

  Lecendreux, Michel ^a,b   Lavault, Sophie ^b,c   Lopez, Régis ^b,d   Inocente, Clara Odilia ^e   Konofal, Eric ^a,b,c   Cortese, Samuele ^f,g   Franco, Patricia ^b,e,h   Arnulf, Isabelle ^b,c   Dauvilliers, Yves ^b,d  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b National Reference Centre for Orphan Diseases   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^d GUI DE CHAULIAC HOSPITAL   (France)

^e LYON NEUROSCIENCE RESEARCH CENTER   (France)

^f UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^g NEW YORK UNIVERSITY   (United States)

^h UNIVERSITÉ LYON 1   (France)

Author keywords

Attention deficit disorder with hyperactivity; Methylphenidate; Modafinil; Narcolepsy; Pediatrics

Indexed keywords

ADRAFINIL; DEXAMPHETAMINE; IMMUNOGLOBULIN; MAZINDOL; MELATONIN; METHYLPHENIDATE; MODAFINIL; OREXIN A; OXYBATE SODIUM; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT; VENLAFAXINE; BENZHYDRYL DERIVATIVE; CENTRAL STIMULANT AGENT;

ADOLESCENT; ADULT; APNEA HYPOPNEA INDEX; ARTICLE; ATTENTION DEFICIT DISORDER; BODY MASS; CATAPLEXY; CHILD; CHILDHOOD DISEASE; CHILDHOOD OBESITY; CLINICAL EXAMINATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DAYTIME SOMNOLENCE; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG MEGADOSE; DSM-IV-TR; FATIGUE; FEMALE; HEALTH SURVEY; HUMAN; INSOMNIA; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; NARCOLEPSY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; REM SLEEP; SLEEP; SLEEP STAGE; SLEEP TIME; STRUCTURED INTERVIEW; STRUCTURED QUESTIONNAIRE; CASE CONTROL STUDY; COMPLICATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FRANCE; INTERVIEW; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PSYCHOLOGY; QUESTIONNAIRE;

ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BENZHYDRYL COMPOUNDS; CASE-CONTROL STUDIES; CATAPLEXY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FATIGUE; FEMALE; FRANCE; HUMANS; INTERVIEWS AS TOPIC; MALE; NARCOLEPSY; SLEEP INITIATION AND MAINTENANCE DISORDERS; SLEEP STAGES; SURVEYS AND QUESTIONNAIRES;

EID: 84938589193     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.4910     Document Type: Article

References (43)

1. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511.
2. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd ed. Westchester, IL: American Academy of Sleep Medicine, 2005.
3. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 3rd ed. Darien, IL: American Academy of Sleep Medicine, 2014.
4. Inocente CO, Lavault S, Lecendreux M, et al. Impact of obesity in children with narcolepsy. CNS Neurosci Ther 2013;19:521-8.
5. Inocente CO, Gustin M-P, Lavault S, et al. Depressive feelings in children with narcolepsy. Sleep Med 2014;15:309-14.
6. Stores G, Montgomery P, Wiggs L. The psychosocial problems of children with narcolepsy and those with excessive daytime sleepiness of uncertain origin. Pediatrics 2006;118:e1116-23.
7. Inocente CO, Gustin MP, Lavault S, et al. Quality of life in children with narcolepsy. CNS Neurosci Ther 2014;20:763-71.
8. Hayes D, Jr. Narcolepsy with cataplexy in early childhood. Clin Pediatr (Phila) 2006;45:361-3.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Arlington, VA: American Psychiatric Publishing, 2013.
10. Cortese S, Konofal E, Lecendreux M. Alertness and feeding behaviors in ADHD: does the hypocretin/orexin system play a role? Med Hypotheses 2008;71:770-5.
11. Lecendreux M, Konofal E, Bouvard M, Falissard B, Mouren-Simeoni MC. Sleep and alertness in children with ADHD. J Child Psychol Psychiatry 2000;41:803-12.
12. Oosterloo M, Lammers GJ, Overeem S, de Noord I, Kooij JJ. Possible confusion between primary hypersomnia and adult attention-deficit/hyperactivity disorder. Psychiatry Res 2006;143:293-7.
13. Walters AS, Silvestri R, Zucconi M, Chandrashekariah R, Konofal E. Review of the possible relationship and hypothetical links between attention deficit hyperactivity disorder (ADHD) and the simple sleep related movement disorders, parasomnias, hypersomnias, and circadian rhythm disorders. J Clin Sleep Med 2008;4:591-600.
14. Modestino EJ, Winchester J. A retrospective survey of childhood ADHD symptomatology among adult narcoleptics. J Atten Disord 2013;17:574-82.
15. Ohayon MM. Narcolepsy is complicated by high medical and psychiatric comorbidities: a comparison with the general population. Sleep Med 2013;14:488-92.
16. De la Herran-Arita AK, Garcia-Garcia F. Current and emerging options for the drug treatment of narcolepsy. Drugs 2013;73:1771-81.
17. Carskadon MA, Dement WC, Mitler MM, Roth T, Westbrook PR, Keenan S. Guidelines for the multiple sleep latency test (MSLT): a standard measure of sleepiness. Sleep 1986;9:519-24.
18. Mignot E, Lammers GJ, Ripley B, et al. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Arch Neurol 2002;59:1553-62.
19. Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991;14:540-5.
20. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-3.
21. Rolland-Cachera MF. Childhood obesity: current definitions and recommendations for their use. Int J Pediatr Obes 2011;6:325-31.
22. Drake C, Nickel C, Burduvali E, Roth T, Jefferson C, Pietro B. The pediatric daytime sleepiness scale (PDSS): sleep habits and school outcomes in middle-school children. Sleep 2003;26:455-8.
23. Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med 2001;2:297-307.
24. Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res 1993;37:147-53.
25. Chalder T, Deary V, Husain K, Walwyn R. Family-focused cognitive behaviour therapy versus psycho-education for chronic fatigue syndrome in 11- to 18-year-olds: a randomized controlled treatment trial. Psychol Med 2009;40:1269-79.
26. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Text Revision. Washington, DC: American Psychiatric Association, 2000.
27. Zhang S, Faries DE, Vowles M, Michelson D. ADHD Rating Scale IV: psychometric properties from a multinational study as a clinicianadministered instrument. Int J Methods Psychiatr Res 2005;14:186-201.
28. DuPaul GJ, Anastopoulos AD, Power TJ, Reid R, Ikeda MJ, McGoey KE. Parent ratings of attention-deficit/hyperactivity disorder symptoms: factor structure and normative data. J Psychopathol Behav Assessment 1998;20:83-102.
29. Smucker MR, Craighead WE, Craighead LW, Green BJ. Normative and reliability data for the Children's Depression Inventory. J Abnorm Child Psychol 1986;14:25-39.
30. Simeoni MC, Auquier P, Antoniotti S, Sapin C, San Marco JL. Validation of a French health-related quality of life instrument for adolescents: the VSP-A. Qual Life Res 2000;9:393-403.
31. Serra-Sutton V, Ferrer M, Rajmil L, Tebe C, Simeoni MC, Ravens-Sieberer U. Population norms and cut-off-points for suboptimal health related quality of life in two generic measures for adolescents: the Spanish VSP-A and KINDL-R. Health Qual Life Outcomes 2009;7:35.
32. Davidian M. Generalized linear models for nonnormal response. In: ST 732 Applied Longitudinal Data Analysis. Raleigh, NC: North Carolina State University, 2005:423-64.
33. Swanson JM, Greenhill LL, Lopez FA, et al. Modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, fixed-dose study followed by abrupt discontinuation. J Clin Psychiatry 2006;67:137-47.
34. The MTA Cooperative Group. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal Treatment Study of Children with ADHD. Arch Gen Psychiatry 1999;56:1073-86.
35. Willcutt EG. The prevalence of DSM-IV attention-deficit/hyperactivity disorder: a meta-analytic review. Neurotherapeutics 2012;9:490-9.
36. Lecendreux M, Konofal E, Faraone SV. Prevalence of attention deficit hyperactivity disorder and associated features among children in France. J Atten Disord 2011;15:516-24.
37. Andlauer O, Moore Ht, Hong SC, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 2012;35:1247-55F.
38. Cortese S, Faraone SV, Konofal E, Lecendreux M. Sleep in children with attention-deficit/hyperactivity disorder: meta-analysis of subjective and objective studies. J Am Acad Child Adolesc Psychiatry 2009;48:894-908.
39. A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002;25:42-9.
40. A 12-month, open-label, multicenter extension trial of orally administered sodium oxybate for the treatment of narcolepsy. Sleep 2003;26:31-5.
41. Lecendreux M, Poli F, Oudiette D, et al. Tolerance and efficacy of sodium oxybate in childhood narcolepsy with cataplexy: a retrospective study. Sleep 2012;35:709-11.
42. Mamelak M, Black J, Montplaisir J, Ristanovic R. A pilot study on the effects of sodium oxybate on sleep architecture and daytime alertness in narcolepsy. Sleep 2004;27:1327-34.
43. de Winter AF, Oldehinkel AJ, Veenstra R, Brunnekreef JA, Verhulst FC, Ormel J. Evaluation of non-response bias in mental health determinants and outcomes in a large sample of pre-adolescents. Eur J Epidemiol 2005;20:173-81.